Session 24 - Neurooncology
Glial and glioneuronal tumors

Programme

• 17:30 – 17:40 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A13

  Investigating regional heterogeneity and progression-associated markers in oligodendrogliomas

  • Thomas Millner (London, GB)
• 17:40 – 17:50 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A14

  CDKN2A/B deletion in IDH-mutant astrocytomas

  • Manali Ranade (Mumbai, IN)
• 17:50 – 18:00 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A15

  Heterochromatin dysfunction impacting genomic topology and superenhancer landscapes underlies ATRX-deficient gliomagenesis

  • Jason Huse (Houston, TX, US)
• 18:00 – 18:10 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A16

  Analysis of the implementation of DNA methylation assay for routine CNS tumors diagnosis

  • Monica Mezmezian (Buenos Aires, AR)
• 18:10 – 18:20 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A17

  A novel type of IDH-wildtype glioma characterized by highly diffuse growth pattern, distinct epigenetic profile and relatively favorable prognosis

  • Amos Münch (Frankfurt a. M., DE)
• 18:20 – 18:30 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A20

  Epigenetically defined angiocentric gliomas may lack angiocentric growth and instead show a variety of growth patterns

  • Annika K. Wefers (Hamburg, DE)
• 18:30 – 18:40 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A18

  Molecular profiling of ependymomas in Indian cohort

  • Mehar Chand Sharma (Delhi, IN)
• 18:40 – 18:50 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A19

  Transcriptomic and epigenetic dissection of spinal ependymomas (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation

  • Karoline Hack (Hamburg, DE)
• 18:50 – 19:00 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A21

  High-grade gliomas occurring in teenagers and young adult patients comprise novel molecular subgroups

  • Matthew Clarke (London, GB)